SCHEMBL16625826

SCHEMBL16625826

C(#Cc1cnc2ccc(-c3ccc(CN4CCOCC4)cc3)nn12)c1ccnc2[nH]ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.43
MAPKAPK2 P49137 1/20 0.40
NEK1 Q96PY6 1/20 0.39
EGFR P00533 1/20 0.38
FLT1 P17948 1/20 0.38
PRKCQ Q04759 2/20 0.38
PRKCD Q05655 2/20 0.38
DYRK1A Q13627 2/20 0.37
MET P08581 1/20 0.37
TGFBR1 P36897 2/20 0.37
JAK2 O60674 1/20 0.37
CHEK1 O14757 3/20 0.37
PIK3CA P42336 1/20 0.37
ATR Q13535 1/20 0.37
CDK2 P24941 1/20 0.36
FLT3 P36888 1/20 0.36
CCNA1 P78396 1/20 0.36
ACVR1 Q04771 1/20 0.36
MAP4K1 Q92918 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16620611 0.84 MKNK1 (0.53) LRRK2FLT1JAK2CHEK1PIK3CA
SCHEMBL17969583 0.79 MET (0.41) LRRK2FLT1PRKCQDYRK1AMET
SCHEMBL24520103 0.79 CHEK1 (0.41) LRRK2FLT1PRKCQDYRK1AMET
SCHEMBL24520016 0.79 CHEK1 (0.42) METTGFBR1CHEK1PIK3CAATR
SCHEMBL16620478 0.77 HRH3 (0.48) DYRK1ATGFBR1JAK2CHEK1HRH3
SCHEMBL16626057 0.76 MKNK1 (0.55) CHEK1PIK3CAATR
SCHEMBL4792087 0.75 NEK1 (0.62) LRRK2MAPKAPK2NEK1FLT1PRKCQ
SCHEMBL24520101 0.74 MKNK1 (0.44) JAK2CHEK1PIK3CAATR
SCHEMBL17969588 0.73 CHEK1 (0.36) METTGFBR1CHEK1PIK3CAATR
SCHEMBL16621059 0.73 CECR2 (0.47) CHEK1PIK3CAATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052501-B1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY SCIENCE TECH & RES (SG) 2022-06-22 EP disclosed
EP-3052501-B1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY SCIENCE TECH & RES (SG) 2022-06-22 EP disclosed
US-10544149-B2 Bicyclic alkyne derivatives and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-01-28 US disclosed
US-10544149-B2 Bicyclic alkyne derivatives and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-01-28 US disclosed
US-20180194771-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-07-12 US disclosed
US-20180194771-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-07-12 US disclosed
US-20180194771-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-07-12 US disclosed
US-9884867-B2 Bicyclic alkyne derivatives and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-02-06 US disclosed
US-9884867-B2 Bicyclic alkyne derivatives and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-02-06 US disclosed
US-9884867-B2 Bicyclic alkyne derivatives and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-02-06 US disclosed
US-20160229860-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2016-08-11 US disclosed
US-20160229860-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2016-08-11 US disclosed
US-20160229860-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2016-08-11 US disclosed
WO-2015050505-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160229860-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF MAPKAPK2, CAMKK2, MKNK2 LRRK2 463/4885MAPKAPK2 1/4885NEK1 78/4885
US-10544149-B2 Bicyclic alkyne derivatives and uses thereof MAPKAPK2, MAP4K2, MKNK2 LRRK2 501/4885MAPKAPK2 1/4885NEK1 80/4885
US-20180194771-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF MAPKAPK2, CAMKK2, MKNK2 LRRK2 463/4885MAPKAPK2 1/4885NEK1 78/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.